DEPLOYDatabase

Robot model

ATLAS 2030

exoskeletoncommercialby Marsi Bionics

Overground pediatric robotic gait training device, first wearable pediatric exoskeleton authorized for clinical use.

Track ATLAS 2030
Manufacturer
Marsi Bionics
Form factor
exoskeleton
Maturity
commercial
Lifecycle
active
Deployments
1

The verified answer

As of Sep 2026, DEPLOY verifies ATLAS 2030, a exoskeleton by Marsi Bionics (commercial): 1 verified deployment on record. 2 sources back the record.

Overview

Overground pediatric robotic gait training device, first wearable pediatric exoskeleton authorized for clinical use. Indicated for cerebral palsy and neuromuscular diseases.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Sources on file
View all sources →

Key facts

Form Factor

exoskeleton

Maturity

commercial

Data & sources

Web sources

2

2 sources backing this record.View all →

Pricing

No verified price is on record for ATLAS 2030. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (1)

Free to use on your site, with a link back to DEPLOY.

ATLAS 2030 on the deployment map

View the global map

Where ATLAS 2030 is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for ATLAS 2030.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (2)

  1. https://www.renishaw.com/de/rls-magnetic-encoders-enable-marsi-bionics-to-build-life-changing-exoskeletons--45522
  2. https://www.eurekalert.org/news-releases/1074217

Common questions

What is ATLAS 2030?
Overground pediatric robotic gait training device, first wearable pediatric exoskeleton authorized for clinical use. Indicated for cerebral palsy and neuromuscular diseases.
How much does ATLAS 2030 cost?
ATLAS 2030's price is not publicly disclosed. DEPLOY has no verified price on record for ATLAS 2030 from Marsi Bionics. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is ATLAS 2030 actually deployed in the real world?
Yes. ATLAS 2030 is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes ATLAS 2030?
ATLAS 2030 is made by Marsi Bionics, based in Madrid, Spain, founded in 2013.
Where is ATLAS 2030 deployed?
1 verified deployment of ATLAS 2030 is on the DEPLOY registry, including at Madrid, Spain.
Can you buy ATLAS 2030?
ATLAS 2030 is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.
What are alternatives to ATLAS 2030?
On the DEPLOY registry, comparable exoskeleton robots to ATLAS 2030 include Ant-H1 Pro, Cyberdyne HAL, German Bionic Cray X, HANK.
How does ATLAS 2030 compare to Ant-H1 Pro?
ATLAS 2030 and Ant-H1 Pro (Kenqing Technology · 5 deployments) are both exoskeleton robots on the DEPLOY registry. ATLAS 2030 has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is ATLAS 2030 a top exoskeleton?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, ATLAS 2030 ranks in roughly the top 69% of exoskeleton models tracked by the registry.
What is ATLAS 2030's maturity stage?
ATLAS 2030 is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.
Is ATLAS 2030 safe?
ATLAS 2030 has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-08-09

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-09

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

2
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for ATLAS 2030.

Recent coverage

ATLAS 2030 in third-party press

A robotic device aids neuromuscular recovery in children with spinal muscular atrophy - Science Media Centre España

May 20, 2026

OTWorld 2026 – International Trade Show and World Congress - Exoskeleton Report

Nov 19, 2025

CPotential continue to expand support for families - NR Times

Jul 8, 2024